Tamoxifen for prevention of breast cancer: extended long-term follow-up of the IBIS-I breast cancer prevention trial

BACKGROUND: Four previously published randomised clinical trials have shown that tamoxifen can reduce the risk of breast cancer in healthy women at increased risk of breast cancer in the first 10 years of follow-up. We report the long-term follow-up of the IBIS-I trial, in which the participants and...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Lancet Oncol
Main Authors: Cuzick, Jack, Sestak, Ivana, Cawthorn, Simon, Hamed, Hisham, Holli, Kaija, Howell, Anthony, Forbes, John F
Format: Artigo
Jezik:Inglês
Izdano: Lancet Pub. Group 2015
Teme:
Articles
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC4772450/
https://ncbi.nlm.nih.gov/pubmed/25497694
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/S1470-2045(14)71171-4
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki